Teva and Alvotech's interchangeable Humira biosimilar joins the party
No more waiting in the wings. Teva and Alvotech won approval Friday for their Humira biosimilar Simlandi after resolving manufacturing issues that caused multiple rejections …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.